 | Up a level |
Dorgalaleh, Akbar and Tabibian, Shadi and Rafiee Alavi, Sayed Ezatolla and Soori, Shahrzad and Asadi, Mansour and Bamedi, Taregh and Moradi, Es’hagh and Shamsizadeh, Morteza and Jalalvand, Masumeh (2016) Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran. HEMATOLOGY. pp. 1-7.
Naderi, Majid and Moradi, Es′hagh and Hosseini, Maryam Sadat and Karimi, Mehran and Dorgalaleh, Akbar and Shamsizadeh, Morteza (2016) Long Term Follow up Study on a Large Group of Patients with Congenital Factor XIII Defciency Treated Prophylactically with Fibrogammin P®. Iranian Journal of Pharmaceutical Research, 15 (2). pp. 635-640.
Naderi, Majid and Hosseini, Maryam S. and Ahmadinejad, Minoo and Moradi, Es’hagh and Shamsizadeh, Morteza and Dorgalalehe, Akbar (2016) Long-term prophylaxis in patients with severe congenital factor XIII deficiency is not complicated by inhibitor formation. Blood Coagulation and Fibrinolysis, 27. pp. 1-4.
